Archives Publications
Abdulkhaleg Ibrahim et al.
MeCP2 is a microsatellite binding protein that protects CA repeats from nucleosome invasion
Science 2021, vol. 372, issue 6549
doi: 10.1126/science.abd5581
Nick Riddiford et al.
Evolution and genomic signatures of spontaneous somatic mutation in Drosophila intestinal stem cells
Genome Research 2021, vol. 31, issue 8
doi: 10.1101/gr.268441.120
Mohamed Belhocine et al.
Dynamics of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes
Genome Research 2021, vol. 32, issue 7
doi: 10.1101/gr.266924.120
Frédéric Mourcin et al.
Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape
Immunity 2021, vol. 54, issue 8
doi: 10.1016/j.immuni.2021.05.019
Elisabetta Stanzani et al.
Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells
Cancers 2021, vol. 13, issue 12
doi: 10.3390/cancers13123055
Mathis Nozais et al.
MYC deficiency impairs the development of effector/memory T lymphocytes
iScience 2021, vol. 24, issue 7
doi: 10.1016/j.isci.2021.102761
Nicolas Huot et al.
CD32+CD4+ T Cells Sharing B Cell Properties Increase With Simian Immunodeficiency Virus Replication in Lymphoid Tissues
Frontiers in Immunology 2021, vol. 12
doi: 10.3389/fimmu.2021.695148
Mohamed Bou Saleh et al.
Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis
Journal of Hepatology 2021, vol. 75, issue 4
doi: 10.1016/j.jhep.2021.05.041
Angela Bellini et al.
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Journal of Clinical Oncology 2021, vol. 39, issue 30
doi: 10.1200/jco.21.00086
Angela Bellini et al.
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Journal of Clinical Oncology 2021, vol. 39, issue 30
doi: 10.1200/jco.21.00086